Ghent University Academic Bibliography

Your filters: cql: author="Benteyn, Daphné" or (type any "bookEditor issueEditor" and editor="Benteyn, Daphné")

Add to list
- Journal Article
- A1
- open access
Current status and perspectives of immune-based therapies for hepatocellular carcinoma

Maridi Aerts, Daphné Benteyn, Hans Van Vlierberghe (UGent) , Kris Thielemans and Hendrik Reynaert

(2016) WORLD JOURNAL OF GASTROENTEROLOGY. 22(1). p.253-261
Add to list
- Journal Article
- A1
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Dufour, Kevin Van Der Jeught, Lukasz Bialkowski, et al.

(2016) CANCER IMMUNOLOGY RESEARCH. 4(2). p.146-156
Add to list
- Book Chapter
Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses

Sandra Van Lint (UGent) , An MT van Nuffel, Sofie Wilgenhof, Daphné Benteyn, Joeri Pen, David Escors, Aude Bonehill, Bart Neyns, Kris Thielemans and Karine Breckpot

(2013) Horizons in Cancer Research, vol. 51. p.1-32
Add to list
- Journal Article
- A1
- open access
Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Daphné Benteyn, Sébastien Anguille, Sandra Van Lint (UGent) , Carlo Heirman, An MT Van Nuffel, Jurgen Corthals, Sebastian Ochsenreither, Wim Waelput, Katrien Van Beneden, Karine Breckpot, et al.

(2013) MOLECULAR THERAPY-NUCLEIC ACIDS. 2.
Add to list
Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot, et al.

(2012) CANCER RESEARCH. 72(7). p.1661-1671

Academic Bibliography

Current status and perspectives of immune-based therapies for hepatocellular carcinoma

Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses

Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Contents

Support

Contact